
Ibolya Csecs MD PhD
@ibolya_csecs
Cardiology & Research Fellow @YaleCardiology | IM @EinsteinMed #Jacobi | CVImaging enthusiast #WhyCMR | 🇭🇺🫀🧲🏃♀️
ID: 4004413341
https://scholar.google.com/citations?hl=en&user=t9yvq28AAAAJ 20-10-2015 20:17:06
285 Tweet
697 Followers
474 Following

#AHA23 1)InHFrEF❗️Amyloidosis Longitudinal strain ‘burned out’ and cardiac function supported by Circumferential strain⭕️ 2)In Multiethnic HFpEF cohort atrial function disproportionately impaired in NHWhite Thankful for mentorship and collaboration, Dr.Garcia & Leandro Slipczuk !


Absolutely loved my time at #AHA23 in Philly. Great science but it is, indeed, all about the people! Great things happening soon to this amazing group of friends! Andrés Daryanani, M.D. Sebastian Santos, MD Carolina .Ricaurte Ibolya Csecs MD PhD Andres Garzona-Navas



A huge welcome to the incoming fellows for 2024! We are thrilled to have you join the Yale Cardiovascular Medicine family 🫀 Yale Internal Medicine Eric J Velazquez Edward Miller, MD PhD Cesia Gallegos, MD MHS FASNC


Who knew slipping and sliding could be this fun? Just had a hilarious ice skating adventure with the Jacobi family! ❄️ Despite a few icy tumbles (including yours truly), we powered through the freezing cold like Winter Warriors! ⛸️🥶 #JacobiStrong Andrew Gutwein MD Jacobi Internal Medicine Chiefs

Thrilled to participate in the first dedicated Sports Cardiology Symposium in Costa Rica 🇨🇷 alongside the great mentor Thomas G. Allison! Gratitude for the chance to learn and contribute to this exciting event! #SportsCardiology


SCMR expert consensus statement for cardiovascular magnetic resonance of patients with a cardiac implantable electronic device #WhyCMR Society for Cardiovascular Magnetic Resonance sciencedirect.com/science/articl…


Happy to present our study about FT-#CMR 🧲strain on a multiethnic cohort 🙋🏿♂️🙋🏽♂️🙋🏻♂️🙋🏼♂️of Apical HCM patients in collaboration with Leandro Slipczuk Montefiore Heart & to connect with 🫀colleagues and friends in Atlanta 🫶🏼 #ACC2024


Great time spent in Atlanta with many friends and colleagues! Superb science and a lot of learning, but it’s really all about the people. What’s next? Let’s fly! 🚀🫀⭐️ #ACC24 Mayo Clinic CV


IM Residency Graduation ✅ Humbled to have been awarded with the teaching recognition by Albert Einstein College of Medicine - Official Finishing residency Jacobi Internal Medicine Chiefs with such incredible memories ☀️ deeply greatful for the people I got to complete this journey with 🫶🏼


Wanted to share a case of a 35-year-old runner 🏃 ,detected with a systolic murmur🫀 by his GP. Thoughts? #SportsCardiology #echofirst Jorge A. Chavarria V. 🇨🇦 🇪🇸 🇨🇷. Eric Bogantes Edgar Fuentes Molina Sanjay Sharma Maximiliano Moreira Prof Michael Papadakis Matthew W Martinez Meagan Murphy Wasfy Jonathan Kim, MD, MSc, FACC, FAHA Eli Gelfand, MD, FACC

PET-MPI in the prediction of CAV in HTx❗️Here we describe the most recent studies & MPI as a potential cost-effective💲alternative to ICA Grateful for the opportunity to work with this brilliant team Attila Feher, MD, PhD Yale Cardiology & Dr. Shreyas Yakkali 🙏🏼 link.springer.com/10.1007/s12410…


Proud to represent Yale Cardiology in the 🌟Early Career Award section at #SCMR2025! Excited to share our results on 🧲CMR characteristics of ~700 patients with Autoimmune Rheumatic Diseases #CardioRheum Thankful for mentorship🙏🏼 Attila Feher, MD, PhD Lauren A. Baldassarre, MD, FACC, FSCCT, FSCMR Edward Miller, MD PhD



Check out our latest paper reporting serial 1+1=✌🏻PET data & longitudinal trends of Myocardial Flow Reserve in ~500 patients referred for CAD evaluation! Yale Cardiology

#Sportscards on fire. New American College of Cardiology and American Heart Association sports eligibility guidelines and now FIRST clinical reference document for Pediatric Sports Cardiology. Led by Peter Dean and American College of Cardiology sports council. Out in JACC Journals now!!


Treat the valve AND the myocardium when facing severe AS+amyloidosis. Both AVR and tafamidis independently ↓ mortality Dual therapy=best outcomes w/ similar survival to lone AS+AVR. Dual pathology is common (~13%) warranting RCT. tinyurl.com/2zmpht8x Bravo Thomas Treibel! 👏🏻
